U.S. Govt. Knows Girls Won’t Get Third Toxic HPV Shot, So They Try PR-ing With Just Two

September 10, 2011 By 1 Comment

Truth Frequency News Published on September 8, 2011 by Sheree USA Today By HealthDay Two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose regimen now being used, new U.S. government research shows. The findings stem from an analysis of data from the National Cancer [...]

[Continue reading...]
Filed Under: Cervarix, Cervarix Clinical Trials, NCI, United States, Vaccine Science Tagged With: , , , , ,

Three HPV Vax Doses May Be Overkill

September 8, 2011 By Leave a Comment

Med Page Today By John Gever, Senior Editor, MedPage Today Published: September 08, 2011 Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. Two doses of a bivalent vaccine against human papillomavirus (HPV) appeared just as effective in preventing persistent infections as the recommended three doses in young women, according to a [...]

[Continue reading...]
Filed Under: Cervarix, Clinical Trials, Gardasil / Silgard, NCI, United States Tagged With: , , , ,

Spinning the Spin Part II: Fewer girls develop cervical abnormalities after HPV vaccine

June 29, 2011 By Leave a Comment

The Marketing of Scientific Research & Studies By Leslie Carol Botha, Vice President of Public Relations, SaneVax Inc. My father, once a pharmaceutical packaging salesman and now an Alzheimer’s nursing home patient whose mental clarity declined rapidly post- flu vaccination – once told me ‘never believe in everything that is advertised.’ Truer advice was never [...]

[Continue reading...]
Filed Under: FDA, HPV, Merck & Co., NCI, World News Tagged With: ,

HPV – NOT Just a Sexually Transmitted Disease

June 27, 2011 By Leave a Comment

By Leslie Carol Botha Studies Identify Transplacental Transmission of HPV & in Blood of Women with Cervical Cancer FDA had to be Aware of Merck’s Unethical Marketing of Gardasil SANE Vax Inc. is bemused and bewildered….with all of the government scientific data and research available to medical consumers via the Internet how does the pharmaceutical [...]

[Continue reading...]
Filed Under: FDA, GlaxoSmithKline, HHS, HPV, HPV Science, Merck & Co., NCI, NIH, World News Tagged With: , , , ,

National Cancer Institute Scientist Admits HPV Vaccines Have Little Value

June 16, 2011 By 1 Comment

By Heidi Stevenson In a misleading article attempting to promote the HPV vaccine, one of their scientists states that most vaccinated girls are at ‘pretty low risk’. The National Cancer Institute (NCI) has issued a bulletin claiming to answer early doubts about the HPV vaccine.(1) It doesn’t, of course, answer the real issue. The vaccine [...]

[Continue reading...]
Filed Under: Cancer, HPV Science, NCI, Vaccine Science Tagged With:

Behind the Scenes: The Evolution of an HPV Industry

April 5, 2011 By 3 Comments

By Norma Erickson, President of SaneVax Inc. The first papillomavirus was discovered in the 1930’s by Dr. Richard E. Shope. It was the cottontail rabbit papillomavirus, or the Shope papillomavirus, which occurred in warts that frequently developed into cancerous tumors1. Dr. Shope was able to isolate the virus, inject it into other rabbits and produce [...]

[Continue reading...]
Filed Under: FDA, GlaxoSmithKline, HPV, Merck & Co., NCI Tagged With: , , , ,

Study Estimates Overall HPV Prevalence in U.S. Women

March 30, 2011 By Leave a Comment

Adapted from the NCI Cancer Bulletin, vol. 4/no. 10, March 6, 2007 (see the current issue 3). Data from the National Health and Nutrition Examination Survey (NHANES) published in the February 28, 2007, Journal of the American Medical Association (JAMA) have provided the first national estimate of the prevalence of human papillomavirus (HPV) infection among [...]

[Continue reading...]
Filed Under: Cancer, HPV Science, NCI Tagged With: , ,

Rogue virus in the vaccine

March 24, 2011 By Leave a Comment

By William Carlsen, Chronicle Staff Writer Early polio vaccine harbored virus now feared to cause cancer in humans. A growing number of medical researchers fear that a monkey virus that contaminated polio vaccine given to tens of millions of Americans in the 1950s and ’60s may be causing rare human cancers. For four decades, government [...]

[Continue reading...]
Filed Under: Cancer, NCI, Vaccine Science Tagged With: , , ,

Human Papillomavirus (HPV) Vaccines

February 24, 2011 By Leave a Comment

Published by the National Cancer Institute (NCI) What are human papillomaviruses?  Human papillomaviruses (HPVs) are a group of more than 100 related viruses. They are called papillomaviruses because certain types may cause warts, or papillomas, which are benign (noncancerous) tumors. The HPVs that cause the common warts that grow on hands and feet are different from [...]

[Continue reading...]
Filed Under: HPV Science, NCI Tagged With: , ,

Private-Public Partnerships in Cancer Vaccine Research

February 14, 2011 By Leave a Comment

By Aleea Farrakh, originally published in “Benchmarks” June 2008 Even though the National Cancer Institute is the leading Federal government agency for cancer research, it is hardly the sole contributor in the fight against cancer. Other government agencies, non-profit organizations, academia and private industry all play critical roles in helping find a cure for the disease. [...]

[Continue reading...]
Filed Under: Cancer, NCI, Vaccine Science Tagged With: , , ,